Simplex Trading
TARA icon

Simplex Trading’s Protara Therapeutics TARA Stock Holding History

Simplex Trading’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.3K Sell
10,800
-19,800
-65% -$94.2K ﹤0.01% 6479
2026
Q1 		$159K Sell
30,600
-26,500
-46% -$157K ﹤0.01% 4573
2025
Q4 		$304K Buy
57,100
+56,000
+5,091% +$311K ﹤0.01% 3796
2025
Q3 		$4K Buy
+1,100
New +$3.56K ﹤0.01% 8441
2025
Q2 		– Sell
-107,700
Closed -$458K – 9712
2025
Q1 		$458K Buy
107,700
+103,500
+2,464% +$462K ﹤0.01% 3481
2024
Q4 		$22K Buy
+4,200
New +$13.6K ﹤0.01% 6621
2024
Q2 		– Sell
-4,100
Closed -$16K – 9795
2024
Q1 		$16K Buy
+4,100
New +$13.2K ﹤0.01% 7288
2023
Q2 		– Sell
-400
Closed -$1K – 9922
2023
Q1 		$1K Sell
400
-500
-56% -$1.65K ﹤0.01% 8777
2022
Q4 		$2K Sell
900
-100
-10% -$316 ﹤0.01% 8655
2022
Q3 		$2K Buy
1,000
+600
+150% +$2.03K ﹤0.01% 9367
2022
Q2 		$1K Sell
400
-2,500
-86% -$9.14K ﹤0.01% 9680
2022
Q1 		$14K Buy
2,900
+2,200
+314% +$11.6K ﹤0.01% 8609
2021
Q4 		$4K Sell
700
-3,600
-84% -$24.8K ﹤0.01% 9714
2021
Q3 		$39K Hold
4,300
– – ﹤0.01% 7834
2021
Q2 		$41K Buy
+4,300
New +$48.7K ﹤0.01% 7898

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Simplex Trading's TARA Position: Q2 2026 in Review

Simplex Trading reduced its Protara Therapeutics (TARA) stake by 92% in Q2 2026, selling an estimated $19.5K and leaving 339 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #8779.

Simplex Trading first reported a position in TARA in Q2 2021 and has held it in 10 quarters since. The position peaked at $77K in Q3 2025. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Simplex Trading held 339 shares of Protara Therapeutics worth $1.29K as of Q2 2026.
  • Simplex Trading sold 4,110 Protara Therapeutics shares in Q2 2026, an estimated $19.5K.
  • Protara Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8779 holding.
  • Simplex Trading first reported a position in Protara Therapeutics in Q2 2021 and has held it in 10 quarters since.
  • Simplex Trading's Protara Therapeutics position peaked at $77K in Q3 2025.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.